T8	Exp 30 34	that
T9	Exp 55 72	the IL-2 promoter
T10	Exp 171 175	that
T11	Exp 190 202	the activity
T12	Exp 206 223	the IL-2 promoter
T13	Exp 227 253	the stimulated T cell line
T14	Exp 277 312	their corresponding nuclear binding
T15	Exp 263 272	The sites
T16	Exp 372 382	The latter
T17	Exp 444 466	the tissue specificity
T18	Exp 537 539	we
T19	Exp 627 641	their presence
T20	Exp 695 699	that
T21	Exp 683 694	the signals
T22	Exp 553 580	these transcription factors
T23	Exp 754 764	the nuclei
T24	Exp 858 884	the signaling requirements
T25	Exp 959 973	the activities
T26	Exp 1086 1093	the CD3
T27	Exp 1265 1307	the protein synthesis inhibitor anisomycin
T28	Exp 1309 1317	Our data
T29	Exp 1328 1340	the activity
T30	Exp 1384 1412	the two signals requirements
R6	Coref Anaphora:T8 Antecedent:T31
R7	Coref Anaphora:T10 Antecedent:T32
R8	Coref Anaphora:T14 Antecedent:T15
R9	Coref Anaphora:T19 Antecedent:T22
R10	Coref Anaphora:T20 Antecedent:T21
T1	Protein 59 63	IL-2
T2	Protein 210 214	IL-2
T3	Protein 354 359	OCT-1
T4	Protein 470 474	IL-2
T5	Protein 829 833	IL-2
T6	Protein 1097 1101	CD28
T7	Protein 1417 1421	IL-2
T31	Exp 0 29	Nuclear transcription factors
T32	Exp 154 170	several elements
